Zhu Jiahui, Ma Rong, Li Gang
Department of Neurology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430022, China.
Department of Pharmacology, School of Basic Medicine, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, 430030, China.
Biomed Pharmacother. 2023 Jan;157:113904. doi: 10.1016/j.biopha.2022.113904. Epub 2022 Nov 9.
Neurodegenerative diseases have been a weighty problem in elder people who might be stricken with motor or/and cognition defects with lower life quality urging for effective treatment. Drugs are costly from development to market, so that drug repurposing, exploration of existing drugs for novel therapeutic purposes, becomes a wise and popular strategy to raise new treatment options. Clemastine fumarate, different from anti-allergic effect as H1 histamine antagonist, was screened and identified as promising drug for remyelination and autophagy enhancement. Surprisingly, fumarate salt also has similar effect. Hence, whether clemastine fumarate would make a protective impact on neurodegenerative diseases and what contribution fumarate probably makes are intriguing to us. In this review, we summarize the potential mechanism surrounding clemastine fumarate in current literature, and try to distinguish independent or synergistic effect between clemastine and fumarate, aiming to find worthwhile research direction for neurodegeneration diseases.
神经退行性疾病一直是老年人面临的一个重大问题,患者可能会出现运动或/和认知缺陷,生活质量较低,迫切需要有效的治疗方法。药物从研发到上市成本高昂,因此药物再利用,即探索现有药物用于新的治疗目的,成为一种明智且流行的策略,以提供新的治疗选择。富马酸氯马斯汀与作为H1组胺拮抗剂的抗过敏作用不同,经筛选被确定为有望促进髓鞘再生和增强自噬的药物。令人惊讶的是,富马酸盐也有类似的效果。因此,富马酸氯马斯汀是否会对神经退行性疾病产生保护作用以及富马酸盐可能发挥何种作用,对我们来说很有吸引力。在这篇综述中,我们总结了当前文献中围绕富马酸氯马斯汀的潜在机制,并试图区分氯马斯汀和富马酸盐的独立或协同作用,旨在为神经退行性疾病找到有价值的研究方向。